MedPath

Lykaspetin

Brand Name: Lykaspetin

Generic Name: Imipenem (as monohydrate) + Cilastatin (as sodium)

Active
Registration Number

DRP-6665

Dosage Form

Powder For Injection (I.V.)

Issuance Date

April 5, 2025

Expiry Date

April 27, 2038

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg/500 mg
Packaging30 mL-capacity USP Type I Clear and Colorless Glass Vial (Box of 1 Vial placed in White Plastic Tray)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Imipenem (as monohydrate)Active
Monograph: imipenem (as monohydrate)
Cilastatin (as sodium)Active
Monograph: cilastatin (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform